Advancing Brain Disease Treatment: Analyzing the Blood-Brain Barrier Market
Major prevalence of neurological disorders and rapidly increasing geriatric population are key factors driving growth of the global blood-brain barrier market
VANCOUVER, BC, CANADA, June 20, 2023/EINPresswire.com/ -- According to the most recent report by Emergen Research, the size of the worldwide blood-brain barrier (BBB) market is anticipated to reach USD 7.40 billion in 2028 at a consistent CAGR during the projected period. The high prevalence of neurological illnesses such Parkinson's disease, Alzheimer's disease, Hunter's syndrome, and brain tumours are significant factors influencing market revenue growth. Rising healthcare costs and increased investment in pharmaceutical research and development are further causes. The blood-brain barrier is crucial in defending the brain against poisonous substances and many blood-borne diseases. Through a specific interchange of components regulated by the blood-brain barrier (BBB) or blood-cerebrospinal fluid (CSF) barrier, it serves to limit the circulation of substances from the circulatory systems to CSF or the brain. The delivery of medications to the brain is also considerably hampered by this function. Drug delivery through this barrier is necessary in the event of central nervous system illnesses in order to provide the proper therapeutic impact to the desired region.
Future market revenue growth is anticipated to be driven by ongoing technical advancements in magnetic resonance imaging technology, which helps to identify the blood-brain barrier, as well as the introduction of advanced nanotechnology and ultrasound applications.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/633
Some Key Findings From the Report:
In January 2021, Nanoform Finland signed an agreement with Herantis Pharma. This agreement will help both companies to improve blood-brain-barrier penetration in nasal drug delivery routes for Parkinson’s therapies using nanoparticle technology.
Parkinson’s disease segment accounted for major revenue share in global market in 2020 and is expected to register a 25.1% CAGR throughout the forecast period. This is attributed to major prevalence of Parkinson’s Disease among an expanding global patient pool.
Asia Pacific is expected to register the fastest revenue CAGR throughout the forecast period, which can be attributed to rapid advancements in pharmaceutical and healthcare infrastructure, increasing aging population, major prevalence of neurological disorders, increasing number of hospitals and long-term care facilities in countries across the globe.
Top competitors of the Blood-Brain Barrier (BBB) Market profiled in the report include:
Allon Therapeutics, Inc., Angiochem Inc., Armagen Technologies, Inc., Bristol-Myers Squibb, BiOasis Technologies, Inc., Sanofi Genzyme, CarThera, Cephalon Inc., Nanomerics, and F. Hoffman La-Roche AG.
Request a discount on the report @ https://www.emergenresearch.com/request-discount/633
For the purpose of this report, Emergen Research has segmented the global blood-brain barrier (BBB) market based on application, technology, end-use, and by region:
Application Outlook (Revenue, USD Billion; 2018–2028)
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Technology Outlook (Revenue, USD Billion; 2018–2028)
Bispecific Antibody RMT Approach
Trojan Horse Approach
Increasing Permeability
Passive Diffusion
Others
End-Use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Surgical centers
Research Institutes
Others
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/blood-brain-barrier-market
Regional Outlook (Revenue: USD Billion; 2018–2028)
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Blood-Brain Barrier (BBB) market size and share for the projected period of 2020-2028
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Blood-Brain Barrier (BBB) market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Explore More Emergen Research Reports @
Chip Scale Package Led Market
https://www.emergenresearch.com/industry-report/chip-scale-package-led-market
Ozone Generation Technology Market
https://www.emergenresearch.com/industry-report/ozone-generation-technology-market
Patent And Trademark Renewals Services Market
https://www.emergenresearch.com/industry-report/patent-and-trademark-renewals-services-market
5g Millimeter Wave Repeater Market
https://www.emergenresearch.com/industry-report/5g-millimeter-wave-repeater-market
Virtual Reality In Medical Market
https://www.emergenresearch.com/industry-report/virtual-reality-in-medical-market
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing Marketresearch and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Eric Lee
Emergen Research
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
